Amazon Pharmacy Competition Is Overblown, Larry Robbins Says at Sohn
Larry Robbins
Photographer: Andrew Harrer/Bloomberg
This article is for subscribers only.
Fears that Amazon.com Inc. will enter the pharmacy-benefits business are dramatically overblown, said Larry Robbins of Glenview Capital Management.
Robbins used the Sohn Conference in New York to reiterate his pitches on McKesson Corp., CVS Health Corp. and Express Scripts Holding Co., saying that competition from Amazon is unlikely to materialize. He sees a 96 percent upside in CVS after its merger with Aetna Inc.